Keebiotic Tablet contains a combination of Amoxycillin (500mg) and Clavulanic Acid (125mg), formulated to provide a broad-spectrum antibacterial effect. Amoxycillin is a semi-synthetic penicillin antibiotic that inhibits bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation by beta-lactamase-producing bacteria, thereby extending its spectrum of activity. Keebiotic is indicated for the treatment of various infections caused by susceptible strains of bacteria, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, otitis media, sinusitis, and dental infections. It is particularly effective against beta-lactamase-producing organisms that are resistant to Amoxycillin alone. The recommended dosage and duration of therapy should be determined by a healthcare professional based on the severity and type of infection, as well as patient-specific factors such as age, renal function, and allergy history. Keebiotic should be used with caution in patients with a history of penicillin allergy or hypersensitivity to beta-lactam antibiotics. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Proper adherence to prescribed dosage is essential to prevent the development of antibiotic resistance.